RCE recce pharmaceuticals ltd

[INTERVIEW] CEO buys another $300,000 stake in Recce Pharmaceuticals (ASX:RCE), page-22

  1. 387 Posts.
    lightbulb Created with Sketch. 729
    Along with the company's other compounds, the mechanism of action and molecular structure of R327 differs very substantially from the traditional antibiotic. As a consequence, those same characteristics have been shown to allow it to exert anti-viral activity as well as anti-bacterial.

    Because of these unusual and more broadly active properties, and also because of the wide potential range of uses, they are being referred to, quite appropriately, as ‘anti-infective’ rather than as ‘anti-biotic’.

    poorinvestor
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.8¢
Change
0.003(0.65%)
Mkt cap ! $112.0M
Open High Low Value Volume
38.5¢ 39.0¢ 38.0¢ $4.167K 10.76K

Buyers (Bids)

No. Vol. Price($)
2 24610 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 49817 1
View Market Depth
Last trade - 15.44pm 31/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.